For decades, the American healthcare landscape has relied on a complex and increasingly fragile system of financial cross-subsidization to maintain operational stability. In this long-standing economic model, high-margin activities and specific payer classes have functioned as a financial life raft for essential but money-losing services. Commercially insured surgical patients have effectively subsidized the care of Medicare, Medicaid, and uninsured populations; meanwhile, hospital outpatient facility fees have been used to offset the chronic losses generated by employed physician groups. This "Jenga tower" of healthcare financing, as industry analysts describe it, is now facing unprecedented structural threats that could lead to a total collapse of the traditional hospital business model.
The most recent and perhaps most significant challenge to this status quo arrived on July 2, 2025, when the Centers for Medicare & Medicaid Services (CMS) issued a series of regulatory updates that targeted two of the most critical pillars of hospital revenue: the 340B Drug Pricing Program and "site-of-service" payment parity for remote ambulatory care. These reductions are not isolated incidents but represent the culmination of a decade-long campaign by well-financed policy advocates and bipartisan legislators to align payments across different care settings and reduce the perceived "hidden taxes" that commercial payers and government programs provide to sustain hospital infrastructure.
The Structural Anatomy of Cross-Subsidization
To understand the magnitude of the current crisis, one must first dissect the specific flows of capital that allow a modern health system to function. For the average American hospital, the "cost" of providing care rarely aligns with the "reimbursement" received for that care. Instead, a series of internal transfers keeps the doors open.
The primary engine of this model is the commercial-to-government subsidy. On average, private insurers pay hospitals significantly more than the actual cost of care—sometimes 200% to 300% of Medicare rates—to compensate for the fact that Medicare and Medicaid often pay less than the cost of delivery. According to data from the American Hospital Association (AHA), underpayment from Medicare and Medicaid reached nearly $100 billion annually in recent years, a gap that must be filled by commercial contracts.
Furthermore, internal service-line subsidies play a vital role. High-acuity service lines, such as orthopedics, cardiology, and neurosurgery, generate the margins necessary to support "mission-critical" but unprofitable programs like behavioral health, neonatal intensive care, and level-one trauma centers. Additionally, the "provider-based" billing model has allowed hospitals to charge higher facility fees for services performed in outpatient clinics compared to independent physician offices. These fees have been the primary mechanism used to underwrite the losses of hospital-employed physician networks, which frequently lose between $150,000 and $250,000 per physician per year.
A Chronology of the Regulatory Squeeze
The transition away from this cross-subsidy model has been building for years, driven by a shifting regulatory philosophy that prioritizes "site-neutral" payments and transparency.
1992 – The Inception of 340B: The 340B Drug Pricing Program was created to help safety-net providers "stretch scarce federal resources" by allowing them to purchase outpatient drugs at significant discounts. Over time, hospitals utilized these savings to fund clinical programs and expand access to care for underserved populations.
2015 – The Bipartisan Budget Act: This legislation introduced the first major "site-neutral" payment restrictions, preventing hospitals from receiving higher outpatient rates for new off-campus facilities. This marked the beginning of the legislative assault on the "facility fee" subsidy.
2018-2022 – The 340B Legal Battles: CMS attempted to slash 340B reimbursements by nearly 30%. While the Supreme Court eventually ruled against the specific methodology of these cuts in 2022, the intent of the federal government remained clear: the 340B "surplus" was a target for redirection.
July 2, 2025 – The CMS Turning Point: The latest CMS rulings have intensified the pressure. By broadening site-neutral payment policies to include more remote ambulatory services and further tightening 340B eligibility and payment structures, the federal government is effectively removing the financial "crutches" that hospitals have used to balance their books.
Supporting Data: The Financial Fragility of 2026
The impact of these changes is already visible in the financial data. Recent reports from healthcare intelligence firms like Strata Decision Technology and Kaufman Hall indicate that the sector is entering a period of prolonged instability. At the start of 2026, health system operating margins began to trend into negative territory for a significant portion of the industry.
Several factors have converged to create this "perfect storm":
- Labor Costs: While the acute nursing shortages of the pandemic era have stabilized, labor expenses remain 20% to 25% higher than 2019 levels, driven by permanent wage increases and a reliance on premium pay.
- Drug and Supply Inflation: Non-labor costs, particularly for specialty pharmaceuticals and medical devices, have climbed at rates exceeding general inflation, often outstripping the annual "market basket" updates provided by CMS.
- The Medicare Advantage Shift: More than 50% of the Medicare population is now enrolled in Medicare Advantage (MA) plans. Unlike traditional fee-for-service Medicare, MA plans often employ aggressive utilization management and lower effective reimbursement rates, further eroding the hospital’s ability to break even on elderly patients.
For hospitals that were not geographically "lucky"—those located in markets with low commercial insurance penetration or high competition—the result has been a wave of consolidations or outright closures. Rural hospitals, in particular, have found the removal of these subsidies to be an existential threat.
Official Responses and Political Pressures
The reaction from the healthcare industry has been one of alarm, while policy advocates argue the changes are overdue. The American Hospital Association has consistently argued that site-neutral cuts are "misguided" because they fail to account for the higher regulatory requirements and 24/7 emergency standby costs that hospitals maintain, which independent clinics do not.
Conversely, organizations such as Arnold Ventures and various employer-led coalitions have pushed for these reforms. Their argument is centered on the "hidden costs" passed on to American families. When a hospital buys a local physician practice and rebrands it as a "hospital outpatient department," the price for a routine procedure can double or triple overnight due to facility fees. Policy advocates argue that these subsidies have allowed hospitals to avoid the hard work of cost management and have instead incentivized aggressive consolidation and price hikes in the commercial sector.
The political pressure is unique in its bipartisanship. Both the left and the right have found reasons to attack the cross-subsidy model. The left views the high commercial prices as an equity issue that prevents affordable access, while the right views the lack of price transparency and "facility fee" markups as a distortion of the free market.
The Path Forward: Breaking the Dependency
The erosion of the cross-subsidy model leaves health system leadership with a stark choice: continue to fight a defensive rearguard action against inevitable regulatory changes or fundamentally restructure their economic foundations. Industry experts, including Brian Fisher of BRG and Jeff Goldsmith of Health Futures, suggest that the path forward requires a level of operational honesty that has been absent for decades.
Commitment to Medicare Breakeven: The most critical strategic shift is the transition to a "Medicare breakeven" mindset. For years, hospitals accepted Medicare losses as a permanent fixture. In the new environment, organizations must rigorously manage the delivered cost of care to align with Medicare’s Diagnosis Related Group (DRG) and Ambulatory Payment Classification (APC) rates. This involves eliminating services that are not sustainably sized, redesigning operating models to reduce overhead, and potentially exiting Medicare Advantage contracts that do not provide a path to margin.
Strategic Service Line Rationalization: Health systems can no longer afford to be "everything to everyone" in every location. This may require closing underperforming programs or consolidating specialized care into regional "centers of excellence" while utilizing lower-cost settings for routine care.
Data-Driven Decision Making: Moving away from the "reimbursement" mindset—where hospitals feel "owed" their costs—requires sophisticated data analytics. Leadership teams must understand the true cost to collect, the true cost of a minute in the OR, and the longitudinal value of a patient relationship versus the immediate margin of a single procedure.
Broader Impact and Long-term Implications
The dissolution of the cross-subsidy era will likely result in a dramatic transformation of the American healthcare landscape. In the short term, we can expect a continued surge in hospital mergers as smaller systems seek the "scale" they believe will protect them. However, scale alone is no longer a shield if the underlying unit economics are flawed.
In the long term, this shift may lead to a more transparent and rational pricing system. If hospitals can no longer hide the costs of social missions and underfunded government programs behind commercial bills and 340B discounts, it will force a national conversation about how "public good" services—like trauma care and medical education—should actually be funded.
The "Jenga tower" is indeed tottering. The recent CMS actions regarding 340B and site-of-service payments are a clear signal that the regulatory environment is no longer willing to support the inefficiencies of the past. For health systems, the time for "kicking the can down the road" has ended. Responsible stewardship now requires the difficult work of building a sustainable, standalone economic model that can survive without the crutch of the cross-subsidy. Only then can these vital institutions continue to serve their communities for the next generation.
